Anne Marie de Jonge–Schuermans becomes board member of the Swiss Biotech Association

Dr. Anne Marie de Jonge–Schuermans was elected as new board member of the Swiss Biotech Association at their general assembly on April 24. She has a PhD from the Swiss Federal Institute of Technology and is Global Head Bio- logics & Injectables Operations at San- doz. Her career has spanned prescrip- tion Pharma/RX, OTC Consumer Health, Generics, Medical Device and Biotech in multiple territories globally.

See the Swiss Biotech Association board & team and have a look at our annual report